Inactive Instrument
Company Cognetivity Neurosciences Ltd. Canadian Securities Exchange
Stocks
CGN
CA19243C1005
Advanced Medical Equipment & Technology
Business description: Cognetivity Neurosciences Ltd.
Sales by Activity: Cognetivity Neurosciences Ltd.
| Fiscal Period: January | 2019 (CAD) | 2020 (CAD) | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) |
|---|---|---|---|---|---|
Development of The ICA Platform | - | - | - | - | 45.37K |
Geographical breakdown of sales: Cognetivity Neurosciences Ltd.
| Fiscal Period: January | 2019 (CAD) | 2020 (CAD) | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) |
|---|---|---|---|---|---|
United Kingdom | - | - | - | - | 45.37K |
Executive Committee: Cognetivity Neurosciences Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Habibi
CEO | Chief Executive Officer | 45 | 31/03/2013 |
Mark Phillips
CMP | Compliance Officer | 67 | 20/12/2017 |
Composition of the Board of Directors: Cognetivity Neurosciences Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Sina Habibi
BRD | Director/Board Member | 45 | 31/12/2016 |
Mark Phillips
BRD | Director/Board Member | 67 | 20/12/2017 |
Company details: Cognetivity Neurosciences Ltd.
Medical Software & Technology Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.18% | +0.33% | -31.65% | -7.55% | 31.97B | |
| -2.08% | -7.54% | -38.54% | +197.51% | 14.42B | |
| -0.21% | -2.07% | -22.14% | +69.77% | 5.7B | |
| -0.82% | -5.75% | - | - | 2.26B | |
| -1.79% | +2.46% | +64.85% | -37.20% | 2.12B | |
| -0.11% | -11.50% | - | - | 1.83B | |
| -1.70% | -2.59% | -31.07% | - | 1.09B | |
| -0.86% | -10.71% | +42.75% | +107.40% | 922M | |
| -1.64% | -2.23% | -35.81% | +245.76% | 821M | |
| Average | -1.16% | -3.72% | -7.37% | +95.95% | 6.79B | |
| Weighted average by Cap. | -1.28% | -3.17% | -27.70% | +57.66% |
Choose MarketScreener 
